Analyst Reco. Artivion, Inc.

Equities

AORT

US2289031005

Market Closed - Nyse Other stock markets 01:30:02 02/05/2024 am IST			5-day change	1st Jan Change
20.33 ^USD	+3.62%		-2.82%	+13.70%

01/03	Artivion Files Mixed Shelf	MT
22/02	Artivion Insider Sold Shares Worth $1,358,818, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stifel Raises Price Target on Artivion to $22 From $20, Maintains Buy Rating	16/02	MT
Morgan Stanley Adjusts Price Target on Artivion to $15 From $14, Maintains Equal-Weight Rating	08/23/08	MT
Needham Adjusts Price Target on Artivion to $26 From $23, Maintains Buy Rating	05/23/05	MT
Needham Adjusts Price Target on Artivion to $23 From $28, Maintains Buy Rating	04/22/04	MT
Morgan Stanley Trims Artivion's Price Target to $14 From $16, Reiterates Equalweight Rating	11/22/11	MT
Oppenheimer Adjusts Artivion's Price Target to $25 From $35, Maintains Outperform Rating	27/22/27	MT
Morgan Stanley Adjusts Artivion's Price Target to $16 from $23, Maintains Equalweight Rating	26/22/26	MT
Oppenheimer Adjusts Artivion Price Target to $25 From $35, Maintains Outperform Rating	26/22/26	MT
Needham Trims Artivion's Price Target to $28 From $29, Reiterates Buy Rating	05/22/05	MT
Morgan Stanley Adjusts Artivion's Price Target to $21 from $23, Keeps Equalweight Rating	15/22/15	MT
Needham Trims Artivion's Price Target to $29 From $30, Reiterates Buy Rating	06/22/06	MT
Stifel Starts Artivion at Buy With $30 Price Target	03/22/03	MT
Needham Adjusts Artivion's Price Target to $30 From $39 on 'Peer Multiple Compression;' Buy Rating Kept	18/22/18	MT
Morgan Stanley Lowers Price Target for CryoLife to $25 From $29, Maintains Equalweight Rating	08/22/08	MT
CRYOLIFE : Needham Adjusts CryoLife's Price Target to $39 From $38, Maintains Buy Rating	30/21/30	MT
CRYOLIFE : Morgan Stanley Starts CryoLife at Equal-Weight With $31 Price Target	15/21/15	MT
CRYOLIFE : Oppenheimer Adjusts CryoLife PT to $35 From $29, Maintains Outperform Rating	30/21/30	MT
CRYOLIFE : Needham Adjusts CryoLife's Price Target to $38 From $33, Maintains Buy Rating	30/21/30	MT
CRYOLIFE : Oppenheimer Adjusts CryoLife PT to $29 From $25, Maintains Outperform Rating	12/21/12	MT
CRYOLIFE : Needham Adjusts CryoLife's Price Target to $28 from $29, Maintains Buy Rating	05/20/05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Artivion, Inc.

Equities

AORT

US2289031005

Analyst Reco.

Filters